Evolution of Dementia Related to the Use of Alcohol in the French Nationwide Discharge Summary Database Between 2007 and 2017.

IF 2.7 4区医学 Q2 CLINICAL NEUROLOGY

American Journal of Alzheimers Disease and Other Dementias Pub Date : 2019-05-01 Epub Date: 2018-12-30 DOI:10.1177/1533317518822043

Michaël Rochoy, Sophie Gautier, Johana Béné, Régis Bordet, Emmanuel Chazard

{"title":"Evolution of Dementia Related to the Use of Alcohol in the French Nationwide Discharge Summary Database Between 2007 and 2017.","authors":"Michaël Rochoy, Sophie Gautier, Johana Béné, Régis Bordet, Emmanuel Chazard","doi":"10.1177/1533317518822043","DOIUrl":null,"url":null,"abstract":"Background: The French nationwide exhaustive hospital discharge database (PMSI) is used for activity-based payment of hospital services. We hypothesized that the release of articles about alcohol and dementia could influence the identification of these diagnoses in PMSI.Methods: We analyzed temporal evolution of coding for dementia and other persistent or late-onset cognitive impairment (OPLOCI) due to alcohol and other psychoactive substances in the PMSI database from 2007 to 2017 (285 748 938 inpatient stays). These codings use the International Classification of Diseases, 10th revision (ICD-10).Results: The number of inpatient stays with dementia and OPLOCI due to alcohol increased from 34 to 1704 from 2007 to 2017. While the number of diagnosed dementias remained stable at around 400 from 2013, the number of OPLOCIs increased 10-fold from 2013 to 2017. This increase was not found with dementia or OPLOCI due to other psychoactive substances than alcohol.Conclusion: Notoriety of a diagnosis in the literature seems to have an impact on the coding.","PeriodicalId":50816,"journal":{"name":"American Journal of Alzheimers Disease and Other Dementias","volume":"34 3","pages":"188-192"},"PeriodicalIF":2.7000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852432/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Alzheimers Disease and Other Dementias","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1533317518822043","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/12/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The French nationwide exhaustive hospital discharge database (PMSI) is used for activity-based payment of hospital services. We hypothesized that the release of articles about alcohol and dementia could influence the identification of these diagnoses in PMSI.

Methods: We analyzed temporal evolution of coding for dementia and other persistent or late-onset cognitive impairment (OPLOCI) due to alcohol and other psychoactive substances in the PMSI database from 2007 to 2017 (285 748 938 inpatient stays). These codings use the International Classification of Diseases, 10th revision (ICD-10).

Results: The number of inpatient stays with dementia and OPLOCI due to alcohol increased from 34 to 1704 from 2007 to 2017. While the number of diagnosed dementias remained stable at around 400 from 2013, the number of OPLOCIs increased 10-fold from 2013 to 2017. This increase was not found with dementia or OPLOCI due to other psychoactive substances than alcohol.

Conclusion: Notoriety of a diagnosis in the literature seems to have an impact on the coding.

查看原文本刊更多论文

2007 年至 2017 年间法国全国出院摘要数据库中与饮酒有关的痴呆症演变情况。

背景：法国的全国性详尽出院数据库（PMSI）用于医院服务的活动付费。我们假设，有关酒精和痴呆症的文章的发布可能会影响 PMSI 对这些诊断的识别：我们分析了 2007 年至 2017 年（285 748 938 次住院）PMSI 数据库中因酒精和其他精神活性物质导致的痴呆和其他持续性或晚发认知障碍（OPLOCI）的编码时间演变。这些编码采用国际疾病分类第十版（ICD-10）：从 2007 年到 2017 年，因酒精导致痴呆和 OPLOCI 的住院人数从 34 人增加到 1704 人。虽然确诊的痴呆症数量从 2013 年起稳定在 400 例左右，但 OPLOCI 的数量从 2013 年到 2017 年增加了 10 倍。除酒精外，其他精神活性物质导致的痴呆症或OPLOCI均未出现这种增长：文献中诊断的知名度似乎对编码有影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Alzheimers Disease and Other Dementias GERIATRICS & GERONTOLOGY-CLINICAL NEUROLOGY

CiteScore

5.40

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： American Journal of Alzheimer''s Disease and other Dementias® (AJADD) is for professionals on the frontlines of Alzheimer''s care, dementia, and clinical depression--especially physicians, nurses, psychiatrists, administrators, and other healthcare specialists who manage patients with dementias and their families. This journal is a member of the Committee on Publication Ethics (COPE).